Dengue Drug Enters Phase II Clinical Trial for COVID-19
Sun Pharma has announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19. The company received approval from the Drugs Controller General of India (DCGI) for…
Read More...
Read More...